Previsioni di mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per dispositivo [elettrocardiografia (ECG), pacemaker, stent, defibrillatore, catetere cardiaco, filo guida, valvola cardiaca, monitor di eventi e altri], applicazione (malattia coronarica , arresto cardiaco improvviso, ictus, cardiopatia cerebrovascolare e altri) e utente finale (ospedali, centri di chirurgia ambulatoriale e centri cardiaci)
Si prevede che il mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico raggiungerà i 14.846,18 milioni di dollari entro il 2028 rispetto agli 8.991,10 milioni di dollari del 2021. Si stima che il mercato crescerà a un CAGR del 7,4% a partire dal 2021 al 2028.
L\'aumento dell\'incidenza delle patologie cardiovascolari nei paesi in via di sviluppo è attribuito allo spostamento negli stili di vita e nell’adozione di strutture modernizzate, portando ad un aumento della prevalenza di altre condizioni di salute associate alle malattie cardiovascolari. La modernizzazione delle strutture residenziali, commerciali e aziendali ha ridotto la necessità di attività fisiche tra le persone; al contrario, i livelli di stress tra le persone stanno aumentando a causa di vari fattori personali e sociali, che stanno guidando la prevalenza delle malattie cardiovascolari nei paesi in via di sviluppo. Inoltre, questi paesi stanno portando sviluppi significativi nelle strutture e nei servizi sanitari basati sui progressi tecnologici. Si prevede che il mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico crescerà a un buon CAGR durante il periodo di previsione.
Entrate dei dispositivi cardiovascolari nell\'Asia del Pacifico e previsioni fino al 2028 (milioni di dollari USA)
< /p>
Segmentazione del mercato dei dispositivi cardiovascolari nell\'Asia Pacifico
Il mercato dei dispositivi cardiovascolari dell\'Asia Pacifico è segmentato in dispositivo, applicazione, utente finale e paese. In base al dispositivo, il mercato è segmentato in elettrocardiografia (ECG), pacemaker, stent, defibrillatore, catetere cardiaco, filo guida, valvola cardiaca, monitor di eventi e altri. Il segmento del monitoraggio degli eventi ha dominato il mercato nel 2020. In termini di applicazione, il mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico è segmentato in malattia coronarica, arresto cardiaco improvviso, ictus, malattia cardiaca cerebrovascolare e altri. Il segmento delle malattie coronariche ha dominato il mercato nel 2020. In base all\'utente finale, il mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico è segmentato in ospedali, centri di chirurgia ambulatoriale e centri cardiaci. Il segmento degli ospedali ha dominato il mercato dei dispositivi cardiovascolari nell’Asia del Pacifico nel 2020. In termini di paese, il mercato dei dispositivi cardiovascolari nell’Asia del Pacifico è segmentato in Cina, Giappone, India, Corea del Sud, Australia e resto dell’Asia del Pacifico. Il Giappone ha dominato il mercato dei dispositivi cardiovascolari nell\'Asia Pacifico nel 2020.
  ;
Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips NV, Siemens Healthineers AG, BD, B. Braun Melsungen AG,  ; e Edwards Lifesciences Corporation sono tra le aziende leader nel mercato dei dispositivi cardiovascolari nell\'Asia del Pacifico.
Asia Pacific Cardiovascular Devices Strategic Insights
Strategic insights for Asia Pacific Cardiovascular Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
Asia Pacific Cardiovascular Devices Report Scope
Report Attribute
Details
Market size in 2021
US$ 8,991.10 Million
Market Size by 2028
US$ 14,846.18 Million
Global CAGR (2021 - 2028)
7.4%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Dispositivo
elettrocardiografia
pacemaker
stent
defibrillatore
catetere cardiaco
guida
valvola cardiaca
monitor di eventi
By Applicazione
malattia coronarica
arresto cardiaco improvviso
ictus
malattia cardiaca cerebrovascolare
By Utente finale
ospedali
centri chirurgici ambulatoriali
centri cardiologici
Regions and Countries Covered
Asia-Pacifico
Cina
India
Giappone
Australia
resto delAsia-Pacifico
Market leaders and key company profiles
Medtronic.
Boston Scientific Corporation.
Abbott.
Jhonson and Jhonson Service Inc.
General Electric Company.
Koninlijke Philips N.V.
Siemens Healthineers AG.
BD.
B.Bruna melsungen AG.
Edwards Lifesciences Corporation.
Get more information on this report
Asia Pacific Cardiovascular Devices Regional Insights
The regional scope of Asia Pacific Cardiovascular Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - Asia Pacific Cardiovascular Devices Market
Medtronic.
Boston Scientific Corporation.
Abbott.
Jhonson and Jhonson Service Inc.
General Electric Company.
Koninlijke Philips N.V.
Siemens Healthineers AG.
BD.
B.Bruna melsungen AG.
Edwards Lifesciences Corporation.
Frequently Asked Questions
How big is the Asia Pacific Cardiovascular Devices Market?
The Asia Pacific Cardiovascular Devices Market is valued at US$ 8,991.10 Million in 2021, it is projected to reach US$ 14,846.18 Million by 2028.
What is the CAGR for Asia Pacific Cardiovascular Devices Market by (2021 - 2028)?
As per our report Asia Pacific Cardiovascular Devices Market, the market size is valued at US$ 8,991.10 Million in 2021, projecting it to reach US$ 14,846.18 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
What segments are covered in this report?
The Asia Pacific Cardiovascular Devices Market report typically cover these key segments-
Utente finale (ospedali, centri chirurgici ambulatoriali, centri cardiologici)
What is the historic period, base year, and forecast period taken for Asia Pacific Cardiovascular Devices Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cardiovascular Devices Market report:
Historic Period : 2019-2020
Base Year : 2021
Forecast Period : 2022-2028
Who are the major players in Asia Pacific Cardiovascular Devices Market?
The Asia Pacific Cardiovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Medtronic.
Boston Scientific Corporation.
Abbott.
Jhonson and Jhonson Service Inc.
General Electric Company.
Koninlijke Philips N.V.
Siemens Healthineers AG.
BD.
B.Bruna melsungen AG.
Edwards Lifesciences Corporation.
Who should buy this report?
The Asia Pacific Cardiovascular Devices Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Asia Pacific Cardiovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Asia Pacific Cardiovascular Devices Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines